Article
TP53 mutations and outcome in osteosarcoma: a prospective, multicenter study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Mar 2005
Wunder Jay S, Gokgoz Nalan, Parkes Robert, Bull Shelley B, Eskandarian Sasha, Davis Aileen M, Beauchamp Chris P, Conrad Ernest U, Grimer Robert J, Healey John H, Malkin David, Mangham D C, Rock Michael J, Bell Robert S, Andrulis Irene L
Abstract excerpt
PURPOSE: Mutations of the TP53 gene have been associated with resistance to chemotherapy as well as poor prognosis in many different malignancies. This is the first prospective study of the prognostic value of somatic TP53 mutations in patients with newly diagnosed extremity osteosarcoma. PATIENT...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
